Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome.

Blood Cancer J · 2019 · PMC6700149 · PMID 31427567

Europe PMC DOI

hedged sentence

0.1206

closest p · 2.4× alpha

0.1206

boldest claim

The sentences

showed a trendp = 0.1206not close (p > 0.1)

MYC breaks showed a trend for inferior EFS (HR 1.601, 95% CI 0.879–2.915, p = 0.1206) and statistically significantly reduced OS (HR 2.531, 95% CI 1.240–5.166, p = 0.0083; Fig. 1c, d ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.